Decheng Capital Global Life Sciences Fund IV, L.P. - Insider Trading & Ownership

Location
C/O Maples Corporate Services Limited, Ugland House, P.O. Box 309, Grand Cayman, Cayman Islands
Summary
The estimated value of insider holdings of Decheng Capital Global Life Sciences Fund IV, L.P. is at least $175M dollars as of February 19, 2025. Decheng Capital Global Life Sciences Fund IV, L.P. is the 10%+ Owner of CG Oncology, Inc. and owns shares of CG Oncology, Inc. (CGON) stock worth about $175M.
Signature
Decheng Capital Global Life Sciences Fund IV, L.P., By Decheng Capital Management IV (Cayman), LLC, its General Partner, By /s/ Xiangmin Cui, Manager
All Insider Reports
All Insider Reports

Ownership of Decheng Capital Global Life Sciences Fund IV, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CGON CG Oncology, Inc. 10%+ Owner $175M Jan 29, 2024
AARD Aardvark Therapeutics, Inc. 10%+ Owner Feb 14, 2025

Insider Transactions Reported by Decheng Capital Global Life Sciences Fund IV, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.